Biomarkers of Renal Cancer

Launched by BIOREK S.R.L. · Mar 14, 2023

Keywords

ClinConnect Summary

This clinical trial, titled "Biomarkers of Renal Cancer," is studying a new testing method to help doctors better understand and diagnose different types of kidney cancers. Researchers want to identify specific markers in blood samples (called liquid biopsies) that can distinguish patients with kidney cancer from those who do not have it, as well as tell apart malignant (cancerous) tumors from benign (non-cancerous) ones. The goal is to make diagnosing kidney cancer more accurate and help determine how aggressive the cancer might be.

To participate in this trial, you must be over 18 years old and of Caucasian descent, with a first diagnosis of a kidney mass. Participants also need to provide informed consent. However, those with a history of active cancer in the past five years, certain genetic conditions, or specific kidney issues may not qualify. If you join the study, you can expect to provide blood samples and share some health information, which will be used to develop a test that could improve how kidney cancer is diagnosed and treated in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria for renal-mass patients:
• • Men and women over 18 years of age
• • Diagnosis of first episode of renal mass
• • Caucasian race
• • Signed, informed consent
• Exclusion Criteria renal-mass patients:
• • Any other concomitant cancer or history of active cancer in the last 5 years
• • Oncological genetic syndrome
• • Previous history of renal tumour
• • Urothelial cancer
• • End-stage renal disease on hemodialysis
• • Bilateral renal cell carcinoma
• Inclusion Criteria for control subjects:
• • Men and women over 18 years of age
• • Caucasian race
• • Living kidney donor or patient with urological functional diseases (e.g. kidney stones, benign prostate hypertrophy, etc..)
• • Signed, informed consent
• Exclusion criteria for control subjects:
• • History of active cancer in the last 5 years
• • Oncological genetic syndrome
• • End-stage renal disease on hemodialysis or peritoneal dialysis